Validated Testing
Our Exposure Test is the first and only peer-reviewed test for the endocrine-disrupting chemicals most linked to reproductive harm. One simple, mail-in urine sample. Results your people can trust.
Million Marker's research-driven program helps employees reduce everyday chemical exposures negatively linked to reproductive health, improving fertility outcomes and IVF success rates while lowering overall fertility treatment costs.
0%
Reduction in fertility-harming chemicals using the Million Marker program
0%
Reduction in harmful exposures
0%
Increase in personal motivation
0%
Made healthier habits
We deliver outcomes that show up in the data and in the lives of your employees. These aren’t projections, these are real statistics derived from our team’s years of rigorous, trailblazing research and peer-reviewed studies.
Read more about
Improve employee health and the success of fertility care outcomes with personalized exposure testing, science-backed reduction programs, and measurable wellness initiatives that attract and retain top talent.
Evidence-based exposure reduction programs that improve fertility outcomes and lower costs across your platform.
Evidence-based exposure reduction programs that improve fertility outcomes and lower costs across your platform.
Bring your clients a fertility benefit that's clinically validated and genuinely novel. Million Marker is the only program of its kind — and a meaningful differentiator in a competitive benefits portfolio.
Our Exposure Test is the first and only peer-reviewed test for the endocrine-disrupting chemicals most linked to reproductive harm. One simple, mail-in urine sample. Results your people can trust.
Comprehensive results are just the beginning. Million Marker for Organizations includes results interpretation, personalized exposure reduction guidance, and ongoing coaching through our CleanPath program.
Every step of the Million Marker experience is designed to fit into your people's lives, not take them over. From mail-in testing to a self-paced behavior change program that targets the highest-impact exposures, we help users make the small but compounding changes that lead to measurable change.
Integrated Solution
One platform for exposure testing, product guidance, and ongoing education
Empowered Choices
Employees get personalized, science-backed recommendations they can act on
Evidence-Based
Testing and recommendations grounded in peer-reviewed research
Real Support
Dedicated resources and ongoing guidance to reduce chemical risk
Measurable Outcomes
Population-level tracking so organizations can see the impact
Fragmented Information
Employees navigate conflicting advice from scattered, unverified sources
Employee Burden
Individuals left on their own with no clear guidance
Unverified Interventions
Unproven detox methods that may be ineffective or harmful
No Accountability
No way to measure or track improvements across a population

Our research shows that exposure to endocrine-disrupting chemicals can lower fertility in both men and women. These chemicals are pervasive in everyday products, and most people have no idea how much they've been exposed to. Testing is the first step to identifying and reducing the exposures that matter most.
Million Marker tests for 13 endocrine-disrupting chemicals across four categories: bisphenols (BPA, BPF, BPS), phthalates, parabens, and oxybenzone: the most common and well-researched hormone disruptors linked to reproductive harm.
Beyond testing, CleanPath provides step-by-step, personalized guidance on reducing each member’s specific exposures. Reduced exposure to hormone-disrupting chemicals is an evidence-based step toward successful conception and a healthier pregnancy.

Our research shows that exposure to endocrine-disrupting chemicals can lower fertility in both men and women. These chemicals are pervasive in everyday products, and most people have no idea how much they've been exposed to. Testing is the first step to identifying and reducing the exposures that matter most.
Million Marker tests for 13 endocrine-disrupting chemicals across four categories: bisphenols (BPA, BPF, BPS), phthalates, parabens, and oxybenzone: the most common and well-researched hormone disruptors linked to reproductive harm.
Beyond testing, CleanPath provides step-by-step, personalized guidance on reducing each member’s specific exposures. Reduced exposure to hormone-disrupting chemicals is an evidence-based step toward successful conception and a healthier pregnancy.

Jenna Hua, RD, MPH, PhD
Chief Executive Officer, Founder

Edwin Uber
Chief Technology Officer

Michael Lathrop
Chief Communications Officer

Christina Ribbens
Chief Operations Officer, Head of People

Jo Rochester, MS, PhD
Chief Scientific Officer

Kim Schultz
Scientist

Jayne Foley, MS, MPH
Research Project Manager

Yan Mia Min, MD, PhD
Data Scientist

Aimee Eyvazzadeh, MD
Medical Advisor

Michael Green
Strategy Advisor

Roy Gerona, PhD
Science Advisor

Brenda Eskenazi, MA, PhD
Science Advisor

Jarod Grossman, PhD
Science Advisor

Christopher Neff
Marketing Advisor

Gay Timmons, MS
Organic Ingredient Advisor

Jenna Hua, RD, MPH, PhD
Chief Executive Officer, Founder

Edwin Uber
Chief Technology Officer

Michael Lathrop
Chief Communications Officer

Christina Ribbens
Chief Operations Officer, Head of People

Jo Rochester, MS, PhD
Chief Scientific Officer

Kim Schultz
Scientist

Jayne Foley, MS, MPH
Research Project Manager

Yan Mia Min, MD, PhD
Data Scientist

Aimee Eyvazzadeh, MD
Medical Advisor

Michael Green
Strategy Advisor

Roy Gerona, PhD
Science Advisor

Brenda Eskenazi, MA, PhD
Science Advisor

Jarod Grossman, PhD
Science Advisor

Christopher Neff
Marketing Advisor

Gay Timmons, MS
Organic Ingredient Advisor
Honest research that delivers real impact
In partnership with the Healthy Nevada Project, Million Marker's personalized Endocrine Disrupting Chemical (EDC) report-back program increased environmental health literacy, reduced EDC biomarker levels, and cut the share of participants who didn't know how to reduce their exposure from 79% to 35%.
In a pilot study of five infertile couples, the Million Marker intervention produced significant reductions in urinary BPA and key phthalate metabolites within 12 weeks. Sperm parameters trended upward in subfertile men, and four of the five couples achieved pregnancy and live birth during follow-up.
A comprehensive review of 91 studies linking BPA to human health outcomes (including infertility, metabolic disease, cardiovascular disease, and neurodevelopment), establishing the scientific basis for why BPA testing matters.
A systematic review demonstrating that BPS and BPF — the chemicals used in "BPA-free" products — have similar hormone-disrupting activity to BPA itself, making the case for why Million Marker tests for all three bisphenols.

Tell us about your organization and we'll put you in touch with the right team members.